Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
Clinical trial NCT00521482 · UNKNOWN
Trial details
- NCT number
- NCT00521482
- Sponsor
- University of Zurich
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.